Literature DB >> 29033157

Midterm Survivorship After Revision Total Hip Arthroplasty With a Custom Triflange Acetabular Component.

Brian P Gladnick1, Keith A Fehring2, Susan M Odum2, Michael J Christie3, David K DeBoer3, Thomas K Fehring2.   

Abstract

BACKGROUND: Custom triflange acetabular components are being increasingly used for the reconstruction of Paprosky type IIIB acetabular defects. However, midterm survivorship data are lacking.
METHODS: We queried the prospective registries at 2 high-volume revision centers for patients who had undergone revision total hip arthroplasty using a custom triflange component between 2000 and 2011. We identified 73 patients with minimum 5-year follow-up. These patients' records were reviewed to determine incidence of revision or reoperation, clinical performance, and radiographic stability. The mean follow-up was 7.5 years (range 5-12 years).
RESULTS: Fifteen of 73 triflange components (20.5%) were indicated for revision during the follow-up period, including 6 for instability (8%) and 8 for infection (11%). Twelve of 73 patients (16%) underwent reoperation for reasons other than failure of the triflange component. The median hip disability and osteoarthritis outcome score for joint replacement score at midterm follow-up was 85 (interquartile range 73-100). Only 1 of 73 implants was determined to be radiographically loose at midterm follow-up.
CONCLUSION: Custom triflange reconstruction for severe acetabular deficiency is a viable option; however, complications are common and significant challenges remain for those that fail.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acetabular deficiency; custom triflange; midterm follow-up; revision total hip arthroplasty; survivorship

Mesh:

Year:  2017        PMID: 29033157     DOI: 10.1016/j.arth.2017.09.026

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  7 in total

1.  Custom triflange revision acetabular components for significant bone defects and pelvic discontinuity: Early UK experience.

Authors:  Hosam E Matar; Veenesh Selvaratnam; Nikhil Shah; Henry Wynn Jones
Journal:  J Orthop       Date:  2020-02-04

2.  [Use of custom-made acetabular components (CMAC) as part of a two-stage procedure in patients with severe periacetabular bone loss].

Authors:  Frank Sebastian Fröschen; Thomas Martin Randau; Sebastian Gottfried Walter; Franz Dally; Dieter Christian Wirtz; Sascha Gravius
Journal:  Oper Orthop Traumatol       Date:  2022-04-01       Impact factor: 1.286

3.  The use of a triflange salvage system for catastrophic pelvic osteolysis after failed total hip arthroplasty.

Authors:  Matthew A Siegel; Michael J Patetta; Jason Y Chen; Diego M Barragan Echenique; Mark H Gonzalez
Journal:  J Orthop       Date:  2021-04-02

4.  Reverse reaming distraction for acetabular reconstruction of chronic pelvic discontinuity.

Authors:  Jing-Yang Sun; Ming Ni; Hai-Yang Ma; Yin-Qiao Du; Jun-Min Shen; Ji-Ying Chen; Yong-Gang Zhou; Guo-Qiang Zhang
Journal:  J Orthop Surg Res       Date:  2020-05-24       Impact factor: 2.359

5.  The mid-long term results of reconstructional cage and morselized allografts combined application for the Paprosky type III acetabular bone defects in revision hip arthroplasty.

Authors:  Qiang Xiao; Haoyang Wang; Kai Zhou; Duan Wang; Tingxian Ling; Fuxing Pei; Zongke Zhou
Journal:  BMC Musculoskelet Disord       Date:  2019-11-07       Impact factor: 2.362

Review 6.  The Diagnosis and Treatment of Acetabular Bone Loss in Revision Hip Arthroplasty: An International Consensus Symposium.

Authors:  Peter K Sculco; Timothy Wright; Michael-Alexander Malahias; Alexander Gu; Mathias Bostrom; Fares Haddad; Seth Jerabek; Michael Bolognesi; Thomas Fehring; Alejandro Gonzalez DellaValle; William Jiranek; William Walter; Wayne Paprosky; Donald Garbuz; Thomas Sculco
Journal:  HSS J       Date:  2021-09-28

7.  A novel revision system for complex pelvic defects utilizing 3D-printed custom prosthesis.

Authors:  Yongqiang Hao; Dinghao Luo; Junxiang Wu; Lei Wang; Kai Xie; Mengning Yan; Kerong Dai; Yongqiang Hao
Journal:  J Orthop Translat       Date:  2021-12-15       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.